JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

DHR

216.47

+0.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

DHR

216.47

+0.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

DHR

216.47

+0.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

DHR

216.47

+0.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

DHR

216.47

+0.36%↑

Search

Intuitive Surgical Inc

Закрыт

СекторЗдравоохранение

487.26 2.36

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

485.74

Макс.

489.74

Ключевые показатели

By Trading Economics

Доход

45M

709M

Продажи

361M

2.9B

P/E

Средняя по отрасли

63.278

84.243

Рентабельность продаж

28.31

Сотрудники

15,638

EBITDA

-60M

956M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+33.72% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

21 апр. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-14B

178B

Предыдущая цена открытия

484.9

Предыдущая цена закрытия

487.26

Новостные настроения

By Acuity

5%

95%

2 / 352 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Weak Bearish Evidence

Intuitive Surgical Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

21 окт. 2025 г., 23:55 UTC

Популярные акции

Stocks to Watch: DraftKings, Texas Instruments, Intuitive Surgical, Pegasystems

21 окт. 2025 г., 21:14 UTC

Отчет
Главные движущие силы рынка

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth -- Update

21 окт. 2025 г., 20:38 UTC

Отчет

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth

22 июл. 2025 г., 21:13 UTC

Отчет

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

23 янв. 2026 г., 16:07 UTC

Отчет

Intuitive Surgical Stock Beats Earnings Estimates. The Stock Is Barely Moving. -- Barrons.com

23 янв. 2026 г., 12:58 UTC

Отчет

Intuitive Surgical Stock Rises on Earnings. What Wall Street Is Saying. -- Barrons.com

22 янв. 2026 г., 21:11 UTC

Отчет

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 янв. 2026 г., 21:11 UTC

Отчет

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 янв. 2026 г., 21:10 UTC

Отчет

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 янв. 2026 г., 21:05 UTC

Отчет

Intuitive Surgical 4Q EPS $2.21 >ISRG

22 янв. 2026 г., 21:05 UTC

Отчет

Intuitive Surgical 4Q Rev $2.87B >ISRG

22 янв. 2026 г., 21:05 UTC

Отчет

Intuitive Surgical 4Q Net $794.8M >ISRG

22 янв. 2026 г., 21:05 UTC

Отчет

Intuitive Surgical 4Q Adj EPS $2.53 >ISRG

22 янв. 2026 г., 21:05 UTC

Отчет

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 532.00 >ISRG

30 окт. 2025 г., 12:38 UTC

Отчет

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

30 окт. 2025 г., 12:01 UTC

Отчет

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

22 окт. 2025 г., 15:42 UTC

Отчет

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22 окт. 2025 г., 12:34 UTC

Отчет

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

22 окт. 2025 г., 11:49 UTC

Отчет

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

21 окт. 2025 г., 20:08 UTC

Отчет

Intuitive Surgical: Worldwide Da Vinci Procedure Growth of Approximately 17% to 17.5% in 2025, Compared to 17% in 2024 >ISRG

21 окт. 2025 г., 20:08 UTC

Отчет

Intuitive Surgical: Non-GAAP Gross Profit Margin to Be Within a Range of 67% and 67.5% of Rev in 2025, Compared to 69.1% in 2024 >ISRG

21 окт. 2025 г., 20:05 UTC

Отчет

Intuitive Surgical 3Q Rev $2.51B >ISRG

21 окт. 2025 г., 20:05 UTC

Отчет

Intuitive Surgical 3Q Net $704.4M >ISRG

21 окт. 2025 г., 20:05 UTC

Отчет

Intuitive Surgical 3Q Adj EPS $2.40 >ISRG

21 окт. 2025 г., 20:05 UTC

Отчет

Intuitive Surgical 3Q Da Vinci Surgical Systems Shipped 427.00 >ISRG

21 окт. 2025 г., 20:05 UTC

Отчет

Intuitive Surgical 3Q EPS $1.95 >ISRG

22 июл. 2025 г., 20:14 UTC

Отчет

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22 июл. 2025 г., 20:13 UTC

Отчет

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22 июл. 2025 г., 20:13 UTC

Отчет

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22 июл. 2025 г., 20:05 UTC

Отчет

Intuitive Surgical 2Q Net $658.4M >ISRG

Сравнение c конкурентами

Изменение цены

Intuitive Surgical Inc Прогноз

Целевая цена

By TipRanks

33.72% рост

Прогноз на 12 месяцев

Средняя 652.73 USD  33.72%

Максимум 750 USD

Минимум 550 USD

Основано на мнении 18 аналитиков Wall Street, спрогнозировавших целевые цены для Intuitive Surgical Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

18 ratings

14

Покупка

4

Удержание

0

Продажа

Техническая оценка

By Trading Central

514.59 / 539.05Поддержка и Сопротивление

Краткосрочная

Weak Bearish Evidence

Среднесрочная

Weak Bullish Evidence

Долгосрочная

Strong Bullish Evidence

Настроения

By Acuity

2 / 352Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat